Evidence map›Paper›PMID 40872916›Full record

ArticleVaccines2025

A Bivalent mRNA Vaccine Efficiently Prevents Gammaherpesvirus Latent Infection.

Yannan Yin, Jinkai Zang, Huichun Shi, Zhuang Wang, Linlin Kuang, Shuxia Wang, Haikun Wang, Ning Li, Xiaozhen Liang, Zhong Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yannan YinShanghai Institute of Immunity and Infection, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Jinkai ZangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Huichun ShiShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Zhuang WangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Linlin KuangShanghai Institute of Immunity and Infection, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Shuxia WangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.
Haikun WangState Key Laboratory of Cardiovascular Diseases, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200092, China.
Ning LiShanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.
Xiaozhen LiangShanghai Institute of Immunity and Infection, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China.
Zhong HuangShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200032, China.ORCID 0000-0002-2161-1359

Funding

National Key Research and Development Program of China 2021YFA1301402Science and Technology Commission of Shanghai Municipality ZD2021CY001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

latent infectionmRNA vaccinemurine gammaherpesvirus 68 (MHV68)neutralizing antibodyT-cell response

Identifiers

PMID40872916
PMCPMC12390394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.